These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 24142146)

  • 21. Challenges in diagnosing narcolepsy without cataplexy: a consensus statement.
    Baumann CR; Mignot E; Lammers GJ; Overeem S; Arnulf I; Rye D; Dauvilliers Y; Honda M; Owens JA; Plazzi G; Scammell TE
    Sleep; 2014 Jun; 37(6):1035-42. PubMed ID: 24882898
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Complex movement disorders at disease onset in childhood narcolepsy with cataplexy.
    Plazzi G; Pizza F; Palaia V; Franceschini C; Poli F; Moghadam KK; Cortelli P; Nobili L; Bruni O; Dauvilliers Y; Lin L; Edwards MJ; Mignot E; Bhatia KP
    Brain; 2011 Dec; 134(Pt 12):3477-89. PubMed ID: 21930661
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Delayed diagnosis, range of severity, and multiple sleep comorbidities: a clinical and polysomnographic analysis of 100 patients of the innsbruck narcolepsy cohort.
    Frauscher B; Ehrmann L; Mitterling T; Gabelia D; Gschliesser V; Brandauer E; Poewe W; Högl B
    J Clin Sleep Med; 2013 Aug; 9(8):805-12. PubMed ID: 23946711
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Presentation of narcolepsy after 40.
    Rye DB; Dihenia B; Weissman JD; Epstein CM; Bliwise DL
    Neurology; 1998 Feb; 50(2):459-65. PubMed ID: 9484372
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The narcoleptic borderland: a multimodal diagnostic approach including cerebrospinal fluid levels of hypocretin-1 (orexin A).
    Bassetti C; Gugger M; Bischof M; Mathis J; Sturzenegger C; Werth E; Radanov B; Ripley B; Nishino S; Mignot E
    Sleep Med; 2003 Jan; 4(1):7-12. PubMed ID: 14592354
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinico-polysomnographic diagnostics of narcolepsy-cataplexy.
    Zachariev Z; Djurkova A
    Folia Med (Plovdiv); 1999; 41(2):5-12. PubMed ID: 10534906
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Narcolepsy: a new perspective on diagnosis and treatment].
    Fronczek R; van der Zande WL; van Dijk JG; Overeem S; Lammers GJ
    Ned Tijdschr Geneeskd; 2007 Apr; 151(15):856-61. PubMed ID: 17472116
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Narcolepsy with cataplexy].
    Dauvilliers Y; Arnulf I
    Rev Neurol (Paris); 2008; 164(8-9):634-45. PubMed ID: 18805301
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Validation of the ICSD-2 criteria for CSF hypocretin-1 measurements in the diagnosis of narcolepsy in the Danish population.
    Knudsen S; Jennum PJ; Alving J; Sheikh SP; Gammeltoft S
    Sleep; 2010 Feb; 33(2):169-76. PubMed ID: 20175400
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Childhood narcolepsy with cataplexy: comparison between post-H1N1 vaccination and sporadic cases.
    Pizza F; Peltola H; Sarkanen T; Moghadam KK; Plazzi G; Partinen M
    Sleep Med; 2014 Feb; 15(2):262-5. PubMed ID: 24468101
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cerebrospinal fluid hypocretin 1 deficiency, overweight, and metabolic dysregulation in patients with narcolepsy.
    Heier MS; Jansson TS; Gautvik KM
    J Clin Sleep Med; 2011 Dec; 7(6):653-8. PubMed ID: 22171205
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Searching for a marker of REM sleep behavior disorder: submentalis muscle EMG amplitude analysis during sleep in patients with narcolepsy/cataplexy.
    Ferri R; Franceschini C; Zucconi M; Vandi S; Poli F; Bruni O; Cipolli C; Montagna P; Plazzi G
    Sleep; 2008 Oct; 31(10):1409-17. PubMed ID: 18853938
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia in narcolepsy.
    Dauvilliers Y; Jennum P; Plazzi G
    Sleep Med; 2013 Aug; 14(8):775-81. PubMed ID: 23219054
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Insufficient non-REM sleep intensity in narcolepsy-cataplexy.
    Khatami R; Landolt HP; Achermann P; Rétey JV; Werth E; Mathis J; Bassetti CL
    Sleep; 2007 Aug; 30(8):980-9. PubMed ID: 17702267
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CSF histamine contents in narcolepsy, idiopathic hypersomnia and obstructive sleep apnea syndrome.
    Kanbayashi T; Kodama T; Kondo H; Satoh S; Inoue Y; Chiba S; Shimizu T; Nishino S
    Sleep; 2009 Feb; 32(2):181-7. PubMed ID: 19238805
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical spectrum of narcolepsy with cataplexy: a reappraisal.
    Sturzenegger C; Bassetti CL
    J Sleep Res; 2004 Dec; 13(4):395-406. PubMed ID: 15560774
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status.
    Krahn LE; Pankratz VS; Oliver L; Boeve BF; Silber MH
    Sleep; 2002 Nov; 25(7):733-6. PubMed ID: 12405608
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pediatric narcolepsy.
    Peterson PC; Husain AM
    Brain Dev; 2008 Nov; 30(10):609-23. PubMed ID: 18375081
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple sleep latency measures in narcolepsy and behaviourally induced insufficient sleep syndrome.
    Marti I; Valko PO; Khatami R; Bassetti CL; Baumann CR
    Sleep Med; 2009 Dec; 10(10):1146-50. PubMed ID: 19464232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A consensus definition of cataplexy in mouse models of narcolepsy.
    Scammell TE; Willie JT; Guilleminault C; Siegel JM;
    Sleep; 2009 Jan; 32(1):111-6. PubMed ID: 19189786
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.